When the coagulation and fibrinolytic cascades are properly balanced the organism is protected from blood loss at the site of vascular injury and yet assured of vascular fluidity elsewhere. When they are not properly balanced, tendencies to bleed or thrombose and their concomitant pathologies exist. The overall objective is to obtain quantitative knowledge of the biochemical properties of the fibrinolytic cascade in order to better understand the regulation of the balance between fibrin deposition and removal. RESEARCH DESIGN AND METHODS. The first and third specific aims will be accomplished by measurements of state and transient kinetics.
The second aim will be accomplished by measuring fluorescence energy transfer.
The fourth aim will be accomplish, with Dr. Tracy, by investigating plasminogen activation and fibrinolysis, in the presence of platelets, plus or minus TAFIa. The fifth aim will be accomplished, in collaboration with Dr. Mann, by searching for perturbations of coagulation by TAFIa and identifying the specific targets of TAFIa in the coagulation cascade. The sixth aim will be accomplished by incorporating the experimental results obtained in aims (1)-(4) into the model which already exists. SIGNIFICANCE. These studies, along withe the others of the Program, should significantly advance our understanding of the regulation of coagulation and fibrinolysis., This information will help attenuate the consequences of pathologic disregulation of these processes such as bleeding, or heart attacks and strokes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL046703-12
Application #
6657102
Study Section
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
$186,685
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Kusak, Piotr; Czarnecka, Danuta; Gissel, Matthew et al. (2016) Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke. Arch Med Sci 12:1000-1007
Bouchard, Beth A; Chapin, John; Brummel-Ziedins, Kathleen E et al. (2015) Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency. Blood 125:3647-50
Brummel-Ziedins, Kathleen E; Everse, Stephen J; Mann, Kenneth G et al. (2014) Modeling thrombin generation: plasma composition based approach. J Thromb Thrombolysis 37:32-44
Bouchard, Beth A; Gissel, Matthew T; Whelihan, Matthew F et al. (2014) Platelets do not express the oxidized or reduced forms of tissue factor. Biochim Biophys Acta 1840:1188-93
de Haan, Hugoline G; Bezemer, Irene D; Vossen, Carla Y et al. (2014) Genetic variants in Cell Adhesion Molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor. Thromb Res 134:1186-92
Undas, A; Brummel-Ziedins, K E; Mann, K G (2014) Anticoagulant effects of statins and their clinical implications. Thromb Haemost 111:392-400
Whelihan, Matthew F; Kiankhooy, Armin; Brummel-Ziedins, Kathleen E (2014) Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation. J Crit Care 29:24-30
Baker, Jason V; Brummel-Ziedins, Kathleen; Neuhaus, Jacqueline et al. (2013) HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2:e000264
Butenas, Saulius (2013) Comparison of natural and recombinant tissue factor proteins: new insights. Biol Chem 394:819-29
Whelihan, Matthew F; Mann, Kenneth G (2013) The role of the red cell membrane in thrombin generation. Thromb Res 131:377-82

Showing the most recent 10 out of 247 publications